HDFC Q1 profit falls 5% YoY to Rs 3,051.5 crore

The profit numbers beat market estimates as a CNBC-TV18 poll had estimated the number to come at Rs 2,698.8 crore.

Non-banking financial heavyweight HDFC, on July 30, announced a 4.7 percent year-on-year (YoY) fall in June quarter standalone net profit at Rs 3,051.5 crore.

In the June quarter of FY20, the company had reported a net profit of Rs 3,203.10 crore.

The profit numbers beat market estimates as a CNBC-TV18 poll had estimated the number to come at Rs 2,698.8 crore.

The company's revenue came at Rs 13,017.7 crore in Q1FY21 against Rs 12,990.3 crore reported in the corresponding quarter last year.

Net interest income (NII) for the June quarter came at Rs 3,392 crore, up 10.17 percent YoY against Rs 3,079 crore in Q1FY20. CNBC-TV18 poll expected NII to come at Rs 3,419.5 crore.

The reported net interest margin (NIM) stood at 3.1 percent against 3.3 percent in the corresponding quarter last year. Adjusting the NIM for the impact of negative carry on account of significantly higher liquidity levels, the NIM stood at 3.3 percent, the same as the previous year, the company said.

The company made a COVID-19 provision at Rs 1,199 crore.

The company said individual loans under moratorium 2 stood at 16.6 percent against 22.6 percent in moratorium 1. Total loans under moratorium 2 stood at 22.4 percent against 27 percent In moratorium 1.

The company said it has a comfortable liquidity position and saw a strong 26 percent YoY growth in deposits.

As of June 30, HDFC's assets under management (AUM) stood at Rs 5,31,555 crore as against 4,75,933 crore in the previous year. Individual loans comprise 74 percent of the total AUM.

On an AUM basis, the growth in the individual loan book was 11 percent while the non-individual loan growth was at 15 percent. The growth in the total loan book was 12 percent, said HDFC.

Capital adequacy stood at 17.3 percent against the regulatory requirement of 14 percent.

Gross non-performing loans as of June 30 stood at Rs 8,631 crore (equivalent to 1.87 percent of the loan portfolio) against Rs 8,908 crore (1.99 percent of loans) as of March 31.

The company said the current and previous year's numbers are not directly comparable due to unprecedented disruption like COVID-19.

The company received a dividend income of Rs 298 crore in Q1FY21. Profit on sale of investments during the quarter stood at Rs 241 crore.

"After adjusting dividend, profit on the sale of investments, net gains on de-recognition of assigned loans, provisioning and the impact of negative carry on account of higher liquidity, the adjusted profit before tax for the quarter stood at Rs 3,265 crore compared to 2,684 crore in the previous year, reflecting a growth of 22 percent," HDFC said.

Comments

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...

Brokerages place bets on Titan, see double-digit upside in the stock

Titan can get benefits from the strong market share in the jewellery and wrist watches segment, mainly driven by a wide range of product portfolio catering mainly to the premium and value-added designer jewellery segment. After three consecutive sessions of losses, shares of Titan Company rose over a percent in morning trade on BSE on September 23. The company was dealt a severe blow by COVID-19 as the pandemic triggered strict lockdowns completely battered the retail sector. In the calendar year so far, shares of this one of the largest, most efficient and profitable specialty retailer in India are 7 percent down. The company reported a net standalone loss of Rs 270 crore for the quarter ended June 2020 as the COVID-19 pandemic hit business. The loss was higher than a CNBC-TV18 poll estimate of Rs 175 crore. Standalone revenue during the quarter declined 62.3 percent year-on-year to Rs 1,862 crore compared to the corresponding period last fiscal. Light at the end ...

Indigo Paints trades at over 55% premium in grey market after IPO price announcement

The grey market premium has increased significantly from Rs 400-500 on January 11 to Rs 840-850 on January 15. Indigo Paints, one of the fastest-growing paint companies in India, was trading at more than 50 percent premium over its higher issue price band of Rs 1,490 per share in the grey market after the announcement of IPO details. The premium in the grey market as of January 15 was at around Rs 840-850 per share, which means the grey market trading price stood at Rs 2,340-2,330 against the issue price of Rs 1,490, as per the data available on IPO Watch. The premium increased significantly from Rs 400-500 on January 11 to Rs 840-850 today. The grey market is an unofficial trading platform where shares get traded well before the allotment in an initial public offering and till the shares get listed on bourses. It generally estimates the expected listing price of a stock. "Currently Asian paints and Berger paints are trading at a PE of 111 and 148, respectively, while Indigo Paint...

SD Solutions

Search This Blog